MBX2329 |
Catalog No.GC64228 |
MBX2329, un puissant inhibiteur du virus de la grippe, inhibe spécifiquement l'entrée virale médiée par l'hémagglutinine (HA) avec le VIH/HA(H5) affichant une IC90 de 8,6 μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1438272-42-4
Sample solution is provided at 25 µL, 10mM.
MBX2329, a potent influenza virus inhibitor, specifically inhibits hemagglutinin (HA)-mediated viral entry with HIV/HA(H5) displaying IC90 of 8.6 μM. MBX2329 inhibits a wide spectrum of influenza A viruses, which includes the 2009 pandemic influenza virus A/H1N1/2009, highly pathogenic avian influenza (HPAI) virus A/H5N1, and oseltamivir-resistant A/H1N1 strains[1].
[1]. Basu A, et al. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. J Virol. 2014;88(3):1447-1460.
Average Rating: 5
(Based on Reviews and 22 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *